Taylor Grosso, Alex Matos and Allison Young of Laserfiche Recognized as 2025 CRN ® Channel Chiefs
4.2.2025 17:00:00 EET | Business Wire | Press release
Laserfiche —a leading enterprise platform that helps organizations manage their most critical content and workflows — today announced that CRN®, a brand of The Channel Company, has named Taylor Grosso, Senior Director, Global Channels and Alliances; Alex Matos, Associate Director – East; and Allison Young, Senior Director, Presales and Service Delivery to the prestigious 2025 CRN® Channel Chiefs list. The annual list recognizes the IT vendor and distribution executives who are driving strategy and setting the channel agenda for their companies.
“Laserfiche’s channel team is committed to continuous investment in our channel partnerships and strengthening our channel ecosystem,” said Laserfiche CEO Karl Chan. “Taylor, Alex and Allison are exemplary channel leaders who empower partners with the tools, training and support they need to deliver exceptional value to our joint customers.”
Young leads Presales and Professional Services at Laserfiche, providing technical expertise and guidance to partners and customers. She has been instrumental in developing and implementing innovative demo and educational resources for the channel. These resources significantly enhance channel partners’ product knowledge, supporting their ability to sell to and service customers, driving mutual success.
Matos is responsible for Laserfiche’s East Coast channel sales. His channel philosophy prioritizes training and development with channel partners to accurately communicate the value and impact of solutions. His efforts have enabled partners to close large deals and improve retention rates, making a significant impact on partner revenue.
Grosso oversees Laserfiche’s global channel sales team, focused on executing a sales model that emphasizes robust education resources, training and support for channel partners. His focus on enterprise sales has allowed partners to unlock new, profitable opportunities. His vision to provide channel partners with robust resources has led to continued growth for Laserfiche’s channel ecosystem.
The Channel Chiefs list, released annually by CRN, showcases the top leaders throughout the IT channel ecosystem who work tirelessly to ensure mutual success with their partners and customers.
“This year’s honorees exemplify dedication, innovation, and leadership that supports solution provider success and fosters growth across the channel,” said Jennifer Follett, VP, U.S. Content, and Executive Editor, CRN, at The Channel Company. “Each of these exceptional leaders has made a lasting channel impact by championing partnerships and designing creative strategies that get results. They’ve set a high bar in the channel, and we’re thrilled to recognize their standout achievements.”
CRN’s 2025 Channel Chiefs list will be featured in the February 2025 print issue of CRN® Magazine and online beginning February 3rd at www.CRN.com/ChannelChiefs.
About Laserfiche
Laserfiche is a leading enterprise platform that helps organizations digitally transform operations and manage their content with AI-powered solutions. Through scalable workflows, customizable forms, no-code templates and AI-enabled capabilities, the Laserfiche® document management platform accelerates how business gets done. Trusted by organizations of all sizes—from startups to Fortune 500 enterprises—Laserfiche empowers teams to boost productivity, foster collaboration, and deliver a superior customer experience at scale. Headquartered in Long Beach, California, Laserfiche operates globally, with offices across North America, Europe, and Asia.
Connect with Laserfiche: Laserfiche Blog | X | LinkedIn | Facebook
About The Channel Company
The Channel Company (TCC) is the global leader in channel growth for the world’s top technology brands. We accelerate success across strategic channels for tech vendors, solution providers, and end users with premier media brands, integrated marketing and event services, strategic consulting, and exclusive market and audience insights. TCC is a portfolio company of investment funds managed by EagleTree Capital, a New York City-based private equity firm. For more information, visit thechannelco.com.
Follow The Channel Company:LinkedIn, X, and Facebook.
© 2025The Channel Company, Inc. CRN is a registered trademark of The Channel Company, Inc. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204485017/en/
Contacts
Linda Domingo
Communications Director, Laserfiche
562-988-1688
Linda.domingo@laserfiche.com
The Channel Company Contact:
Kristin DaSilva
The Channel Company
kdasilva@thechannelcompany.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CAIRDAC Adds Operational Expertise to Its Board of Directors With the Appointment of Rinda Sama9.11.2026 14:44:00 EET | Press release
CAIRDAC, SA, a pre-revenue-stage medtech company developing ALPS™, a leadless, self-powered cardiac pacing system, today announced the appointment of Mr. Rinda Sama to its Board of Directors. His appointment adds deep manufacturing, quality and operational experience to the Board and follows the recent appointment of Raymond W. Cohen as Chairman. “Mr. Sama’s extensive experience in manufacturing, quality systems and operational scale-up for complex implantable devices will be extremely valuable to our Company as we prepare for clinical evaluation and the next stages of development,” said Edouard Fonck, Chief Executive Officer of CAIRDAC. Mr. Sama currently serves as CEO of Spiro Medical, a company focused on treating asthma employing a proprietary neuromodulation system. He previously served as Chief Operating Officer of publicly traded Axonics, Inc. where he was accountable for manufacturing and quality and the operational infrastructure that supported the company’s commercial growth.
Nominations Open for Sixth Edition of Aster Guardians Global Nursing Award 2027 Worth USD 250,000 Prize9.11.2026 14:35:00 EET | Press release
Aster DM Healthcare has announced the launch of the sixth edition of the Aster Guardians Global Nursing Award, inviting registered nurses worldwide to showcase their contributions to healthcare and compete for a prize of USD 250,000. The award recognises nurses whose work advances patient care, strengthens healthcare systems, drives innovation and transforms communities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261109180902/en/ Aster Guardians Global Nursing Award - One nurse will win the trophy and the prize of USD 250,000 (Photo: AETOSWire) Open to registered nurses worldwide, the award recognises contributions across five areas: Patient Care, Nursing Education, Social and Community Service, Research and Innovation, and Nursing Leadership and Administration. Applicants can share their professional journeys through case-study questions, in multiple languages at www.asterguardians.com until December 31, 2026. The 2026
Datavault AI and Biochar Now Combine Insured Carbon Removal Credits with Patented Tokenization Technology9.11.2026 13:45:00 EET | Press release
Datavault AI Inc. (“Datavault” or the “Company”) (Nasdaq: DVLT), today announced a global strategic collaboration with Biochar Now to expand the distribution of verified, insured carbon removal credits through Datavault’s patented tokenization technology and global marketing and distribution capabilities. The partnership is designed to connect Biochar Now’s carbon removal credits with a broader network of buyers while strengthening transparency, traceability and accountability in the carbon markets. Under the agreement, Datavault AI will provide access to its carbon credit tokenization technology, including U.S. Patent No. 12,443,977 and related pending applications. It will also support worldwide demand generation, buyer development, marketing and distribution of eligible Biochar Now carbon credits, while also pursuing listings with existing and future partner exchange platforms. Biochar Now will pay Datavault AI for its technology and services; specific financial terms were not discl
NIQ to Present at 2026 J.P. Morgan Ultimate Services Investor Conference9.11.2026 13:45:00 EET | Press release
NielsenIQ (NYSE: NIQ) (the “Company”, or “NIQ”), a leading global consumer intelligence company, today announced that Jim Peck, Chairman and CEO, and Mike Burwell, CFO will participate in a fireside chat at the J.P. Morgan Ultimate Services Investor Conference on Tuesday, November 17, 2026 at 2:40 pm ET. A live webcast will be available on the NIQ investor relations website at https://investors.nielseniq.com. A replay will also be available on the Company's website following the conclusion of the presentation. About NielsenIQ NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior. Combining an unmatched global data footprint, granular consumer and retail measurement, and decades of AI modeling expertise, NIQ helps companies turn complex data into confident action. With operations in more than 90 countries covering approximately 82% of the world’s population and more than $7.4 trillion in consumer spend, N
Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression9.11.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the Company completed its submission of a New Drug Application (NDA) to the U.S. FDA for COMP360 psilocybin, its investigational synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). "People living with treatment-resistant depression have gone too long experiencing disproportionate suffering, despite years of trying available treatment options without meaningful relief. The completion of our NDA submission reflects years of perseverance and commitment by patients, families, advocates, researchers and healthcare providers who have worked alongside us toward the shared goal of bringing new treatment options to this community,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “Compass is leading the development of this new class of medicines with rigor and discipline, successfully
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom